270 related articles for article (PubMed ID: 21494254)
21. Notch1 downregulation combined with interleukin-24 inhibits invasion and migration of hepatocellular carcinoma cells.
Han B; Liu SH; Guo WD; Zhang B; Wang JP; Cao YK; Liu J
World J Gastroenterol; 2015 Sep; 21(33):9727-35. PubMed ID: 26361419
[TBL] [Abstract][Full Text] [Related]
22. Preclinical analysis of the γ-secretase inhibitor PF-03084014 in combination with glucocorticoids in T-cell acute lymphoblastic leukemia.
Samon JB; Castillo-Martin M; Hadler M; Ambesi-Impiobato A; Paietta E; Racevskis J; Wiernik PH; Rowe JM; Jakubczak J; Randolph S; Cordon-Cardo C; Ferrando AA
Mol Cancer Ther; 2012 Jul; 11(7):1565-75. PubMed ID: 22504949
[TBL] [Abstract][Full Text] [Related]
23. FBW7 mutations in leukemic cells mediate NOTCH pathway activation and resistance to gamma-secretase inhibitors.
O'Neil J; Grim J; Strack P; Rao S; Tibbitts D; Winter C; Hardwick J; Welcker M; Meijerink JP; Pieters R; Draetta G; Sears R; Clurman BE; Look AT
J Exp Med; 2007 Aug; 204(8):1813-24. PubMed ID: 17646409
[TBL] [Abstract][Full Text] [Related]
24. Notch signalling in primary cutaneous CD30+ lymphoproliferative disorders: a new therapeutic approach?
Kamstrup MR; Biskup E; Gniadecki R
Br J Dermatol; 2010 Oct; 163(4):781-8. PubMed ID: 20560956
[TBL] [Abstract][Full Text] [Related]
25. Inhibition of gamma-secretase activity impedes uterine serous carcinoma growth in a human xenograft model.
Groeneweg JW; Hall TR; Zhang L; Kim M; Byron VF; Tambouret R; Sathayanrayanan S; Foster R; Rueda BR; Growdon WB
Gynecol Oncol; 2014 Jun; 133(3):607-15. PubMed ID: 24667249
[TBL] [Abstract][Full Text] [Related]
26. The γ-secretase inhibitor GSI-I interacts synergistically with the proteasome inhibitor bortezomib to induce ALK+ anaplastic large cell lymphoma cell apoptosis.
Dang Q; Chen L; Xu M; You X; Zhou H; Zhang Y; Shi W
Cell Signal; 2019 Jul; 59():76-84. PubMed ID: 30878517
[TBL] [Abstract][Full Text] [Related]
27. Identification of a Pan-Gamma-Secretase Inhibitor Response Signature for Notch-Driven Cholangiocarcinoma.
O'Rourke CJ; Matter MS; Nepal C; Caetano-Oliveira R; Ton PT; Factor VM; Andersen JB
Hepatology; 2020 Jan; 71(1):196-213. PubMed ID: 31211856
[TBL] [Abstract][Full Text] [Related]
28. GSI-I has a better effect in inhibiting hepatocellular carcinoma cell growth than GSI-IX, GSI-X, or GSI-XXI.
Shen Y; Lv D; Wang J; Yin Y; Miao F; Dou F; Zhang J
Anticancer Drugs; 2012 Aug; 23(7):683-90. PubMed ID: 22569108
[TBL] [Abstract][Full Text] [Related]
29. Gamma-secretase inhibitors reverse glucocorticoid resistance in T cell acute lymphoblastic leukemia.
Real PJ; Tosello V; Palomero T; Castillo M; Hernando E; de Stanchina E; Sulis ML; Barnes K; Sawai C; Homminga I; Meijerink J; Aifantis I; Basso G; Cordon-Cardo C; Ai W; Ferrando A
Nat Med; 2009 Jan; 15(1):50-8. PubMed ID: 19098907
[TBL] [Abstract][Full Text] [Related]
30. Alpha-secretase inhibition reduces human glioblastoma stem cell growth in vitro and in vivo by inhibiting Notch.
Floyd DH; Kefas B; Seleverstov O; Mykhaylyk O; Dominguez C; Comeau L; Plank C; Purow B
Neuro Oncol; 2012 Oct; 14(10):1215-26. PubMed ID: 22962413
[TBL] [Abstract][Full Text] [Related]
31. Gamma secretase inhibitors enhance vincristine-induced apoptosis in T-ALL in a NOTCH-independent manner.
Yoon SO; Zapata MC; Singh A; Jo WS; Spencer N; Choi YS
Apoptosis; 2014 Nov; 19(11):1616-26. PubMed ID: 25156146
[TBL] [Abstract][Full Text] [Related]
32. In vivo manifestation of Notch related phenotypes in zebrafish treated with Alzheimer's amyloid reducing gamma-secretase inhibitors.
Yang T; Arslanova D; Xu X; Li YM; Xia W
J Neurochem; 2010 Jun; 113(5):1200-9. PubMed ID: 20345767
[TBL] [Abstract][Full Text] [Related]
33. Gamma-Secretase Inhibitor IX (GSI) Impairs Concomitant Activation of Notch and Wnt-Beta-Catenin Pathways in CD44
Barat S; Chen X; Cuong Bui K; Bozko P; Götze J; Christgen M; Krech T; Malek NP; Plentz RR
Stem Cells Transl Med; 2017 Mar; 6(3):819-829. PubMed ID: 28186678
[TBL] [Abstract][Full Text] [Related]
34. PSEN1-selective gamma-secretase inhibition in combination with kinase or XPO-1 inhibitors effectively targets T cell acute lymphoblastic leukemia.
Govaerts I; Prieto C; Vandersmissen C; Gielen O; Jacobs K; Provost S; Nittner D; Maertens J; Boeckx N; De Keersmaecker K; Segers H; Cools J
J Hematol Oncol; 2021 Jun; 14(1):97. PubMed ID: 34167562
[TBL] [Abstract][Full Text] [Related]
35. Gamma-secretase inhibitors--do they have a role in the treatment of B cell lymphoma?
Swaminathan S
Cancer Biol Ther; 2009 Nov; 8(22):2144-6. PubMed ID: 20068386
[No Abstract] [Full Text] [Related]
36. Inhibition of gamma-secretase affects proliferation of leukemia and hepatoma cell lines through Notch signaling.
Suwanjunee S; Wongchana W; Palaga T
Anticancer Drugs; 2008 Jun; 19(5):477-86. PubMed ID: 18418214
[TBL] [Abstract][Full Text] [Related]
37. Notch-regulation upon Dll4-stimulation of TGFb-induced apoptosis and gene expression in human B-cell non-Hodgkin lymphomas.
Hajdu M; Kopper L; Sebestyén A
Scand J Immunol; 2010 Jan; 71(1):29-37. PubMed ID: 20017807
[TBL] [Abstract][Full Text] [Related]
38. Atonal homolog 1 is required for growth and differentiation effects of notch/gamma-secretase inhibitors on normal and cancerous intestinal epithelial cells.
Kazanjian A; Noah T; Brown D; Burkart J; Shroyer NF
Gastroenterology; 2010 Sep; 139(3):918-28, 928.e1-6. PubMed ID: 20621629
[TBL] [Abstract][Full Text] [Related]
39. Molecular dependence of estrogen receptor-negative breast cancer on a notch-survivin signaling axis.
Lee CW; Raskett CM; Prudovsky I; Altieri DC
Cancer Res; 2008 Jul; 68(13):5273-81. PubMed ID: 18593928
[TBL] [Abstract][Full Text] [Related]
40. Inhibition of Notch signaling induces apoptosis of myeloma cells and enhances sensitivity to chemotherapy.
Nefedova Y; Sullivan DM; Bolick SC; Dalton WS; Gabrilovich DI
Blood; 2008 Feb; 111(4):2220-9. PubMed ID: 18039953
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]